Anti-ulcer pharmaceutical compositions containing salicylic acid or its salts


The invention relates to new anti- ulcer and anti-ulcer/antiinflammatory compositions and products, which contain an anti-ulcer agent or a salt thereof and salicylic acid or an alkali metal salt thereof optionally together with a nonsteroidal antiinflammatory agent. As an anti-ulcer agent preferably cimetidine or ranitidine is employed, while the preferred non-steroidal antiinflammatory agent is indomethacin.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)


Cited By (7)

    Publication numberPublication dateAssigneeTitle
    GB-2197787-AJune 02, 1988Glaxo Group LtdAnti-inflammatory compositions
    GB-2197787-BNovember 21, 1990Glaxo Group LtdAnti-inflammatory compositions
    US-4855293-AAugust 08, 1989Glaxo Group LimitedAnti-inflammatory compositions comprising a systemic non-steroidal anti-inflammatory drug and a cyclopentyl ether
    US-5068249-ANovember 26, 1991Glaxo Group LimitedAqueous ranitidine compositions stabilized with ethanol
    US-5260333-ANovember 09, 1993Bristol Myers Squibb CompanyEffect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
    WO-9215332-A1September 17, 1992Warner-Lambert CompanyNovel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
    WO-9414431-A1July 07, 1994Richter Gedeon Vegyészeti Gyár Rt.Gastrocytoprotective pharmaceutical composition and process for the preparation thereof